Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06931340 |
| Title | Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial |
| Acronym | ASPIRE |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Alliance for Clinical Trials in Oncology |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |